We have shown that individual patient data on patient factors, for example, comorbid medical conditions, social determinants, tumor characteristics (e.g., hormone receptors), HER2 Neu expression, diagnosis, treatments and follow‐up outcomes can be extracted from this platform and assembled to characterize the care patients receive throughout their journey. This evidence concerns the gene NR4A1 and neoplasm.